X0306 4 2020-12-23 0001358762 REATA PHARMACEUTICALS INC RETA 0001372218 CPMG Inc 2000 MCKINNEY AVE., STE 2125 DALLAS TX 75201 true true Class A common stock 2020-12-23 4 J 0 63481 D 0 I By Flamingo Fund, LP Class A common stock 2020-12-23 4 J 0 103185 D 0 I By Blackwell Partners LLC Class A common stock 116512 I By Nighthawk Partners, LP Class A common stock 282246 I By Willet Fund, LP Class A common stock 137962 I By Killdeer Fund, LP Class A common stock 5464 I By Elepaio Partners, LP Class A common stock 44200 I By Barred Owl Partners, LP Class A common stock 34897 I By Managed Account for Trustees of the University of Pennsylvania Class A common stock 442560 I By Gallopavo, LP Class A common stock 748253 I By Roadrunner Fund, LP Class A common stock 431155 I By Yellow Warbler, LP Class A common stock 109415 I By Mallard Fund, LP Class A common stock 37909 I By Crested Crane, LP Class A common stock 334740 I By Sandpiper Fund, LP Class A common stock 160265 I By Kestrel Fund, LP Class A common stock 11076 I By CD Fund, LP Class A common stock 134 I By Redbird Life Sciences Partners, LP Class A common stock 113 D The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania and a managed account of Blackwell Partners LLC - Series A (the "Blackwell Account"). The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. The transaction represents the distribution of shares by Flamingo Fund, LP to its sole limited partner. No sale of shares was made by the Reporting Person or Flamingo Fund, LP in connection with the transaction. The transaction reflects 1.3% of the 4,756,424 Class A and Class B shares of the issuer beneficially owned by the Reporting Person prior to the date of the transaction. The transaction represents the revocation of the Reporting Person's investment discretion with respect to the shares held by the Blackwell Account. No distribution or sale of shares was made by the Reporting Person in connection with the transaction. The transaction reflects 2.2% of the 4,756,424 Class A and Class B shares of the issuer beneficially owned by the Reporting Person prior to the date of the transaction. Mr. McGaughy, Jr., the sole director and sole shareholder of the Reporting Person, serves on the Issuer's Board of Directors (the "Board") as a representative of the Reporting Person. By virtue of his representation on the Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person is deemed to be a director by deputization. /s/ John Bateman, Chief Operating Officer of CPMG, Inc. 2020-12-29